Article
Phosphoglycerate kinase 1 as a therapeutic target in neurological disease
14 Apr 2025
Abstract excerpt
Phosphoglycerate kinase 1 (PGK1) is a highly conserved enzyme that catalyzes the initial ATP-producing step in glycolysis. Improving cellular energy production by increasing PGK1 activity may be beneficial in multiple neurological conditions where cell metabolism is dysregulated, including Parkinson's disease (PD) and motor neuron disease (MND). This review examines recent evidence that suggests increasing PGK1...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
